Month: October 2024

Die KI Claude 3.5 Sonnet bekommt ein Update und kann nun Rechner durch Mausbewegungen und Tasteneingaben fernsteuern. (KI, API)

Das neue Premium-SoC Snapdragon 8 Elite soll von Qualcomm acht Generationen lang Unterstützung bekommen. Diese müssen Hersteller aber auch nutzen. (Snapdragon 8 Elite, Smartphone)

Das Boox Palma 2 und das Boox Note Air 4C kommen mit geringfügigen Verbesserungen gegenüber den Vorgängermodellen. Die Preise der Eink-Geräte bleiben gleich. (E-Book-Reader, Tablet)

Die Optimierung der Effizienz von IT-Systemen ist eine zentrale Aufgabe von Betriebsverantwortlichen, um Kosten zu senken und Nachhaltigkeit zu erreichen. In diesem Intensiv-Workshop werden zukunftsweisende Strategien vorgestellt. (Golem Karrierewelt, Server-Applikationen)

The Onyx BOOX Palma 2 is an eBook reader that looks like a smartphones. It has a 6.13 inch, 824 x 1648 pixel capacitive touch display with 300 pixels per inch. But this isn’t a phone – it’s a pocket-sized eBook reader with a black and white E ink Carta 1200 screen covered with a […]

The post Onyx BOOX Palma 2 pocket-sized eReader has a faster processor, quicker page refresh, and a fingerprint sensor appeared first on Liliputing.

United Launch Alliance has started assembling its next Vulcan rocket—the first destined to launch a US military payload—as the Space Force prepares to certify it to loft the Pentagon's most precious national security satellites.

Space Force officials expect to approve ULA's Vulcan rocket for military missions without requiring another test flight, despite an unusual problem on the rocket's second demonstration flight earlier this month.

ULA has launched two Vulcan test flights. Military officials watched closely, gathering data to formally certify the rocket is reliable enough to launch national security missions. The first test flight in January, designated Cert-1, was nearly flawless. The Cert-2 launch October 4 overcame an anomaly on one of Vulcan's strap-on solid rocket boosters, which lost its exhaust nozzle but kept firing with degraded thrust.

Read full article

Comments

Colossal, the company founded to try to restore the mammoth to the Arctic tundra, has also decided to tackle a number of other species that have gone extinct relatively recently: the dodo and the thylacine. Because of significant differences in biology, not the least of which is the generation time of Proboscideans, these other efforts may reach many critical milestones well in advance of the work on mammoths.

Late last week, Colossal released a progress report on the work involved in resurrecting the thylacine, also known as the Tasmanian tiger, which went extinct when the last known survivor died in a zoo in 1936. Marsupial biology has some features that may make de-extinction somewhat easier, but we have far less sophisticated ways of manipulating it compared to the technology we've developed for working with the stem cells and reproduction of placental mammals. But, based on these new announcements, the technology available for working with marsupials is expanding rapidly.

Cane toad resistance

Colossal has branched out from its original de-extinction mission to include efforts to keep species from ever needing its services. In the case of marsupial predators, the de-extinction effort is incorporating work that will benefit existing marsupial predators: generating resistance to the toxins found on the cane toad, an invasive species that has spread widely across Australia.

Read full article

Comments

Amid ongoing legal battles over coveted GLP-1 therapies, a drug vendor in Washington state is accused of running an outlandish scheme to sell do-it-yourself kits to make illicit knockoff versions of weight-loss and diabetes drugs, Zepbound and Mounjaro.

For the alleged scheme, vendor Pivotal Peptides has customers buy a set of ingredients they have to mix together to create their own injectable versions of the drugs. Customers don't need a prescription or even a medical consultation to order the kit, even though the brand-name drugs are prescription-only. That may not be surprising, though, since the dubious white powder customers receive is stated to be "a research chemical for lab research and veterinary purposes only." Once purchased, the kit's instructions recommend users disinfect their home work surface before beginning and stress the importance of using the sterile water included in the kit to dissolve the powder to the desired concentration. The instructions then explain how to inject oneself with the homemade mixture using a 30-gauge syringe.

That's all according to a lawsuit filed Monday by pharmaceutical giant Eli Lilly, maker of tirzepatide-based Zepbound and Mounjaro, which are sold as ready-to-use medicines in single-dose pens or vials. The lawsuit against Pivotal Peptides is one of three that Lilly filed this week, all accusing questionable drugmakers of unlawfully selling knockoff versions of its tirzepatide drugs that have not been tested or approved. But the one against Pivotal Peptides stands out for the scheme the owners allegedly used to sell their knockoff version.

Read full article

Comments

Subscription fees for video streaming services have been on a steady incline. But despite subscribers paying more, surveys suggest that viewers are becoming less satisfied with what's available to watch.

At the start of 2024, the industry began declaring the end of Peak TV, a term coined by FX Networks chairman John Landgraf, refers to an era of rampant content spending that gave us shows like The Wire, Breaking Bad, and Game of Thrones. For streaming services, the Peak TV era meant trying to lure subscribers with original content that was often buoyed by critical acclaim and/or top-tier actors, writers, and/or directors. However, as streaming services struggle to reach or maintain profitability, 2024 saw a drop in the number of new scripted shows for the first time in at least 10 years, FX Research found.

Meanwhile, overall satisfaction with the quality of content available on streaming services seems to have declined for the past couple of years. Most surveys suggest a generally small decline in perceived quality, but that’s still perturbing considering how frequently streaming services increase subscription fees. There was a time when a streaming subscription represented an exclusive ticket to viewing some of the best new TV shows and movies. But we’ve reached a point where the most streamed TV show last year was Suits—an original from the USA Network cable channel that ended in 2019.

Read full article

Comments

The Bigme B1051C is an Android 14 tablet with a MediaTek Dimensity 900 processor, 6GB of RAM, 128GB of storage, and a microSD card with support for up to 1TB of removable storage. But unlike most Android tablets, the B1051C has an E Ink Color display, which means it’s primarily designed for reading and writing rather […]

The post Bigme B1051C is a 10.3 inch E Ink Color tablet with Android 14 appeared first on Liliputing.